Analystreport

MEI Pharma (NASDAQ: MEIP) is now covered by analysts at Laidlaw. They set a "buy" rating and a $7.00 price target on the stock.

MEI Pharma, Inc.  (MEIP) 
Last mei pharma, inc. earnings: 2/6 04:02 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.meipharma.com